Ovarian stimulation protocol with ultra flexible and ultra simplified start for oocyte donors

Phase 1

• Conditions: infertility; MedDRA version: 20.0Level: PTClassification code 10021926Term: InfertilitySystem Organ Class: 10038604 - Reproductive system and breast disorders; Therapeutic area: Body processes [G] - Reproductive physiologi cal processes [G08]

• Registration Number: EUCTR2018-003106-29-FR
• Lead Sponsor: CHI Créteil

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-09-25
• Last Update Posted: 5 April 2021

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: Female
• Target Recruitment: 110

Inclusion Criteria

- Donor of oocytes having spontaneous and regular menstrual cycles, and having taken no hormonal treatment (in particular contraceptive) during the cycle preceding the donation.
- Patient with normal ovarian reserve with antral follicle count> 8,
- BMI between 18 and 32
- Regular natural menstrual cycles, and absence of hormonal treatment during the cycle preceding the donation cycle
- Major patient
- Affiliation to social security
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 110
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- Stage 3-4 endometriosis
- ovarian cyst> 30 mm,
- Polycystic ovary syndrome
- Patient under tutorship or curatorship

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified